| 依达拉奉与前列地尔脂微球载体靶向制剂联合治疗急性脑梗死的疗效观察 |
| |
| 引用本文： | 赵群.依达拉奉与前列地尔脂微球载体靶向制剂联合治疗急性脑梗死的疗效观察[J].中国医药指南,2012,0(24):438-439. |
| |
| 作者姓名： | 赵群 |
| |
| 作者单位： | 徐州医学院附属第三医院,江苏徐州221003 |
| |
| 摘 要： | 目的探讨依达拉奉与前列地尔脂微球载体靶向制剂联合治疗急性脑梗死的临床疗效。方法选择80例急性脑梗死患者随机分为治疗组(40例)和对照组(40例),治疗组在常规治疗的基础上给予依达拉奉和前列地尔脂微球载体靶向制剂。结果观察两组治疗后临床疗效,治疗组总有效率95.0%显著优于对照组(75.0%)。结论依达拉奉与前列地尔脂微球载体靶向制剂联合治疗急性脑梗死安全、有效。
|
| 关 键 词： | 依达拉奉 前列地尔脂微球载体靶向制剂 脑梗死 |
Edaravone with Alprostadil Lipid Microsphere Carrier Targeting Agents in the Treatment of Acute Cerebral Infarction |
| |
| ZHAO Qun.Edaravone with Alprostadil Lipid Microsphere Carrier Targeting Agents in the Treatment of Acute Cerebral Infarction[J].Guide of China Medicine,2012,0(24):438-439. |
| |
| Authors: | ZHAO Qun |
| |
| Institution: | ZHAO Qun (the Third Affiliated Hospital of Xuzhou Medical College, Xuzhou 221003, China) |
| |
| Abstract: | Objective To study of Edaravone and alprostadil lipid microsphere carder targeting agents in the treatment of acute cerebral infarction. Methods 80 cases of acute cerebral infarction were randomly divided into treatment group （40 cases） and control group （ n = 40）, the treatment group was treated with routine therapy on the basis of Edaravone and alprostadil lipid microsphere carder targeting preparation. Results In two groups were observed after treatment of clinical efficacy, the treatment group was significantly better than the control group. Conclusion Edaravone with alprostadil lipid microsphere carder targeting preparation combined with safe, effective treatment of acute cerebral infarction. |
| |
| Keywords: | Edaravone Alprostadil lipid microsphere carrier targeting preparation Cerebral infarction |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
